Contributor biographical information for Preclinical safety evaluation of biopharmaceuticals : a science-based approach to facilitating clinical trials / [edited by] Joy A. Cavagnaro.

Bibliographic record and links to related information available from the Library of Congress catalog

Biographical text provided by the publisher (may be incomplete or contain other coding). The Library of Congress makes no claims as to the accuracy of the information provided, and will not maintain or otherwise edit/update the information supplied by the publisher.

Joy A. Cavagnaro, PhD, is the President of Access BIO, a consultancy specializing in science-based regulatory strategies and product development services. She has over twenty-five years of experience in biotech spanning academia, the CRO and biotech industries, and government. During her tenure at the FDA, Dr. Cavagnaro served as rapporteur for ICH S6. She is founder and past chair of the BIO Preclinical Safety Expert Group (BioSafe) and was the U.S. BIO Representative to the 2006 ABPI/BIA Early Stage Clinical Trials Taskforce.Dr. Cavagnaro is currently North American Chair of the Drug Information Association-Biotech SIAC and Chair of the Clinical and Regulatory Affairs Committee of the American Society of Gene Therapy. She serves on a number of scientific advisory boards and lectures internationally in the area of preclinical development of novel therapies.

Library of Congress subject headings for this publication:
Pharmaceutical biotechnology -- Safety measures.
Drugs -- Testing.
Clinical Trials as Topic -- methods.
Biological Products.
Clinical Trials as Topic -- legislation & jurisprudence.
Drug Evaluation, Preclinical -- methods.